Clinical Trial

Effect of Antioxydant-enriched Media on Blastocyst Euploidy Rates.

Study acronym: GX
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 21, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
One of the most sensible factors in IVF culture conditions is the susceptibility of gametes and embryos to an induced increase in reactive oxidative species (ROS) caused by the artificial environment. This study aims to evaluate the impact of using antioxidant-supplemented media during culture to evaluate embryo ploidy rates in a prospective randomized trial using sibling oocytes.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-02-08; most recent amendment 2025-02-20.
Status change: Not Yet Recruiting → Recruiting 2024-07-30
Trial Details
NCT Number NCT06261671
Lead Sponsor ART Fertility Clinics LLC
Conditions Infertility, In Vitro Fertilization
Enrollment 500 participants
Start Date 2024-02-01
Primary Completion 2025-12-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-02-21